Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT05960994
Eligibility Criteria:
Inclusion Criteria for Intensive care units:
* Intensive care units from public or philanthropic hospitals.
* Intensive care units with physician and nurses available 24 hours a day and physiotherapist available at least ≥ 18 hours a day.
Exclusion Criteria for Intensive care units:
* Intensive care units with structured multidisciplinary round more than three times a week conducted by an intensive care physician (certified), documented in the medical record, with a fixed duration (\>5 min / patient), using some supporting tool (checklist or standard form), goal oriented, based on established protocols, including all the patients admitted to the ICU.
* Intensive care units already doing audit and feedback with specific planning.
* Dedicated coronary care units/cardiac intensive care units or other specialized units (cardiac surgery, neurological, burned patients).
* Step-down units or semi-intensive cardiac care unit.
* Intensive care units without availability of substitute renal therapy.
* ICU coordinator specialist in intensive care medicine and management training (MBA in Health Management or equivalent).
Inclusion Criteria for patients:
* Adult patients (≥ 18 years old).
Exclusion Criteria for patients:
* Admission for other reasons than medical (e.g., judicial cause, legal reasons, safety reasons).
* Previously included in the TELESCOPE II trial (for the primary outcome analysis).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05960994
Study Brief:
Protocol Section:
NCT05960994